Address

China Development Industrial Bank
Taipei,
Taiwan

Open map


Recent investment activity

KANDO id: 39555

Corporate information

Also known as
CDIB
Registration country

Company type

Private development financial institution in Taiwan.

Funding rounds

Top investment portfolio themes
sensors (1)  

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 1 - 23 of 23
Profile Country Date Sort descending Funding
Dynavax Technologies Corp N/A
Yazam Inc N/A
Inovise Medical Inc Diagnostic medical technology company that is shaping cardiac care worldwide. N/A
WebEx Communications Inc Web conferencing company. N/A
ZettaCom Inc N/A
AuthenTec Inc AuthenTec is a leading provider of mobile and network security. N/A
PTC Therapeutics Inc Biopharmaceutical company. N/A
Wintegra Provider of access processing semiconductors enabling the delivery of new services for the evolving communications network infrastructure. N/A
Acorda Therapeutics Inc A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders. N/A
IC Media Corp Electronics/Chips & Semiconductors company based in Santa Clara, California. N/A
Inapac Technology Inc N/A
R2 Technology Inc N/A
InnoPath Software Inc N/A
Nanosys Inc Nanotechnology-enabled systems N/A
Icagen Inc Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases. N/A
Zeevo Inc N/A
Optimer Pharmaceuticals Inc Global biopharmaceutical company. N/A
MontaVista Software LLC N/A
Nereus Pharmaceuticals Inc Series B
Aderis Pharmaceuticals Inc Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. Series D Initial investment
Entropic Communications Inc Fabless semiconductor company. Series B Initial investment
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. Series C
Light Sciences Oncology Inc Drug-device cancer therapy Series A

Current team

Past employees

Selected Products / Customers

Financials